Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN114181168A enables efficient synthesis of high-purity benzothiazinone intermediates with enhanced supply chain reliability and cost savings.
Patent CN112159312B enables high-purity triarylmethane synthesis through novel catalytic cascade, reducing lead time and production costs for pharmaceutical intermediates.
Patent CN113735778B enables high-purity 5-trifluoromethyl imidazole production through silver oxide catalysis, reducing lead time and scaling complex intermediates for pharmaceutical applications.
Novel chiral phosphoric acid catalysis enables high-purity API intermediates with reduced lead time and scalable production for pharmaceutical applications.
Patent CN113880781B introduces glucose-based triazole synthesis with mild conditions and scalable production, reducing lead time and costs for high-purity pharmaceutical intermediates.
Patent CN110590788B enables high-purity 2-acyl-pyrroloindole API intermediates through visible-light catalysis, reducing manufacturing costs and lead times.
Patent CN111039737B enables mild visible-light catalysis for high-purity pharmaceutical intermediates with scalable production reducing manufacturing costs.
Patent CN107573276B enables high-purity indolinone synthesis via NHC catalysis, reducing lead time and costs while ensuring reliable supply chain for pharmaceutical intermediates.
Patent CN107573276B enables high-purity indolinone intermediates through green NHC catalysis with one-pot processing reducing lead time and manufacturing costs.
Novel chiral quaternary ammonium salt catalyst enables asymmetric alkylation with superior stereoselectivity while reducing lead time and production costs for pharmaceutical intermediates.
Novel axial chiral phosphine-ene ligand enables high-yield asymmetric allylation with mild conditions, reducing manufacturing costs and lead times for fine chemicals.
Rhodium-catalyzed synthesis of carbazole compounds enables high-purity fine chemicals with broad substrate adaptability and reduced manufacturing costs.
Patent CN113735756A enables high-yield enantioselective synthesis under mild conditions, enhancing supply chain reliability and reducing pharmaceutical manufacturing costs.
Patent CN119060057B enables scalable synthesis of indolocyclopentane compounds with mild conditions, reducing manufacturing costs and ensuring reliable supply chain for pharmaceutical intermediates.
Patent CN118126005B enables metal-free synthesis of high-purity dihydrobenzofuran intermediates, reducing lead time and manufacturing costs for pharmaceutical applications.
Patent CN114524701B enables high-purity chiral pyrrole synthesis with mild conditions, enhancing cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN114524701B enables high-purity N-N axis chiral pyrrole intermediates through mild catalytic synthesis, reducing manufacturing costs and ensuring reliable pharmaceutical supply chains.
Novel visible-light catalyzed synthesis of 3-aryl-2H-indazoles enables high-purity pharmaceutical intermediates with reduced manufacturing costs and faster scale-up.
Patent CN116253692A enables metal-free triazine synthesis at room temperature, reducing manufacturing costs and ensuring supply chain continuity for pharmaceutical intermediates.
Recent patent reveals chiral isothiourea-catalyzed synthesis of N-axis chiral indole amides with mild conditions and high enantioselectivity enabling cost reduction and reliable supply for pharmaceutical intermediates.